A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

China biotech inks $135M deal for remaining rights to vTv med

Having secured regional rights to vTv’s inflammation drug, Newsoara is fronting $20 million to take ownership of the clinical-stage asset globally.
James Waldron Feb 2, 2026 10:10am
RNA Concept 3D Render

Roche continues RNA return with $1.7B deal for Sanegene drug

Feb 2, 2026 8:35am
Inside Henlius global growth strategy

Inside Henlius’ global growth strategy

Feb 2, 2026 8:00am
gold bank vault door

Santé Ventures closes $330M fund for biotech, medtech and more

Feb 2, 2026 8:15am
Dark and dramatic sky with sunlight

Skye links CB1-Wegovy combo to 22.3% weight loss after a year

Feb 2, 2026 8:08am
x

Fierce Biotech Layoff Tracker 2026: Bitterroot, IO Biotech & more

Feb 2, 2026 6:00am
More News

Sanofi GCS inhibitor fails ph. 3 Fabry trial but wins in Gaucher

Feb 2, 2026 5:46am

CRO Sygnature Discovery plans to send 60 UK staffers packing

Jan 30, 2026 5:00pm

Corcept submitted lead asset for approval despite FDA warning

Jan 30, 2026 2:01pm

Moderna's latest CMO steps down after barely a year

Jan 30, 2026 10:58am